• Introduction
  • Why Almac?
  • People
  • Facilities
• Biomarker Discovery and Validation
  • Companion Diagnostics
  • Pharmacodynamic Biomarkers
  • Prognostic tests
  • Drug Repositioning
  • Consultancy
• Bioinformatics Solutions
  • Gene Selection
  • Signature generation
  • Functional analysis
• Genomic services
  • Gene Expression and SNP analysis
  • qPCR and cell line modelling
  • Bioinformatics
• Cancer DSA™
  • Unique Content
  • Work with FFPE and fresh frozen tissue
  • Discover Targets, signatures and answers
• Resources
  • Technical Documentation
  • Posters and presentations
  • Publications

Translating science to targeted patient care

Almac Diagnostics is a personalised medicine company whose core expertise is in the provision of genomic-based solutions from our laboratories in EU and USA.

We have our own pipeline of genomics based IVD tests in development, all of which have been developed from FFPE tissue.

We utilise our experience, expertise and our unique Cancer DSA ™ technology to partner with customers enabling translational genomic solutions for personalised medicine.

Our solutions:

• Biomarker discovery and validation
• Bioinformatic solutions
• Genomic services including our own proprietary Cancer DSA™ technology